• AI
  • Molecular Imaging
  • CT
  • X-Ray
  • Ultrasound
  • MRI
  • Facility Management
  • Mammography

Acuson reports stable first quarter

Article

Ultrasound vendor Acuson of Mountain View, CA, reported single-digit growth in sales for its first quarter (end-April), while net income dipped slightly. The company reported that U.S. sales remain stable, while international shipments increased 4%

Ultrasound vendor Acuson of Mountain View, CA, reported single-digit growth in sales for its first quarter (end-April), while net income dipped slightly. The company reported that U.S. sales remain stable, while international shipments increased 4% thanks to the shipment of a large order to China.

For the period, Acuson logged $119 million in sales, up 2.8% compared with $115.8 million in revenues in the first quarter of 1998. The company posted net income of $5.5 million in the quarter, compared with net income of $5.7 million in the corresponding quarter a year ago. Acuson’s operating income was higher this quarter than a year ago, but the company’s net profit was reduced by a $1 million charge for interest expense.

Related Videos
Where the USPSTF Breast Cancer Screening Recommendations Fall Short: An Interview with Stacy Smith-Foley, MD
A Closer Look at MRI-Guided Transurethral Ultrasound Ablation for Intermediate Risk Prostate Cancer
Improving the Quality of Breast MRI Acquisition and Processing
Can Fiber Optic RealShape (FORS) Technology Provide a Viable Alternative to X-Rays for Aortic Procedures?
Does Initial CCTA Provide the Best Assessment of Stable Chest Pain?
Making the Case for Intravascular Ultrasound Use in Peripheral Vascular Interventions
Can Diffusion Microstructural Imaging Provide Insights into Long Covid Beyond Conventional MRI?
Assessing the Impact of Radiology Workforce Shortages in Rural Communities
Emerging MRI and PET Research Reveals Link Between Visceral Abdominal Fat and Early Signs of Alzheimer’s Disease
Reimbursement Challenges in Radiology: An Interview with Richard Heller, MD
Related Content
© 2024 MJH Life Sciences

All rights reserved.